Loading…
Ultralife Corporation is projected to rise to $6.34 by 2027, a +22% move from its current price of $5.19. ULBI is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $5.10 | $5.19 | $5.29 | +0.06% |
| Aug 6 | $5.06 | $5.20 | $5.34 | +0.12% |
| Aug 7 | $5.03 | $5.20 | $5.37 | +0.18% |
| Aug 8 | $5.01 | $5.20 | $5.40 | +0.24% |
| Aug 9 | $4.99 | $5.21 | $5.43 | +0.30% |
| Aug 10 | $4.97 | $5.21 | $5.46 | +0.35% |
| Aug 11 | $4.96 | $5.21 | $5.48 | +0.41% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.96 | $5.21 | $5.48 | +0.41% |
| Week 2 | $4.87 | $5.23 | $5.62 | +0.83% |
| Week 3 | $4.82 | $5.25 | $5.73 | +1.25% |
| Week 4 | $4.77 | $5.28 | $5.83 | +1.67% |
| Week 5 | $4.74 | $5.30 | $5.93 | +2.09% |
| Week 6 | $4.70 | $5.32 | $6.02 | +2.51% |
| Week 7 | $4.68 | $5.34 | $6.10 | +2.93% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems.
Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Communications Systems segment provides communications systems and accessories to support military communications systems, such as radio frequency amplifiers, power supplies and cables, connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, and integrated communication systems for fixed or vehicle applications comprising vehicle amplifier-adaptors, vehicle installed power enhanced rifleman appliqué systems, and SATCOM systems. The company sells its products under the Ultralife, Ultralife HiRate, Ultralife Thin Cell, Lithium Power, McDowell Research, AMTI, ABLE, ACCUTRONICS, ACCUPRO, ENTELLION, SWE Southwest Electronic Energy Group, SWE SEASAFE, Excell Battery Group, Criterion Gauge, and POW-R BMS brands through original equipment manufacturers, and industrial and defense supply distributors. In addition, it sells its 9-volt battery to the broader consumer market through national and regional retail chains and online retailers.
It serves government, defense, and commercial sectors. The company was incorporated in 1990 and is headquartered in Newark, New York.
Ultralife Corporation (Industrials) is a public company valued at $87.78M with a current price of $5.27 and a market ranking of 4014. The stock has a defined 30-day technical picture and a multi-year forecast showing a path of gradual-to-bullish appreciation from 2027 onward, with notable growth expected by 2040 and 2050.
The latest price sits near defined support and the near-term range, while the longer-horizon forecast outlines rising average prices and increasing ROIs through 2030, 2040, and 2050. The current price, market cap, and forecast imply a mid-to-long-term upside potential within the stated ranges.
A major floor 17.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.6% away) — a key level to hold.
The nearest ceiling, 24.5% above — a clean break opens room to run.
A major ceiling 53.2% above — clearing it would confirm fresh momentum.
Key ULBI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ULBI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.28 | Sell | $5.26 | Sell |
| MA 10 | $5.33 | Sell | $5.35 | Sell |
| MA 20 | $5.55 | Sell | $5.55 | Sell |
| MA 50 | $6.17 | Sell | $5.95 | Sell |
| MA 100 | $6.45 | Sell | $6.20 | Sell |
| MA 200 | $6.27 | Sell | $6.39 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 31.58 | Neutral |
| Stoch RSI (14) | 51.76 | Neutral |
| CCI (20) | -105.59 | Sell |
| Williams %R (14) | -94.92 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -9.74 | Sell |
| Bollinger %B (20,2) | 0.16 | Neutral |
| Stochastic %K (14) | 5.08 | Buy |
| TRIX (15) | -0.64 | Sell |
| Awesome (5,34) | -0.57 | Sell |
| Ultimate (7,14,28) | 28.10 | Buy |
| Momentum (10) | -0.32 | Sell |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 5.20 | Sell |
| ADX (14) | 29.56 | Sell |
| ATR (14) | 0.10 | Info |
Technical snapshot for the past 30 days shows RSI14 at 30 and a neutral sentiment. The 50-day simple moving average sits at $6.32 and the 200-day simple moving average at $6.34, indicating near-term resistance around $6.69 and support at $5.27.
The 30-day price range spans $4.56 to $6.09, illustrating a relatively tight trading window around the current level. Overall, near-term momentum remains neutral with potential for a test of resistance near the $6.69 level if buying pressure increases.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.16 | $5.19 | $6.65 | 0% | Neutral | |
| $5.19 | $6.34 | $8.08 | +22% | Bullish | |
| $5.13 | $6.38 | $8.36 | +23% | Bullish | |
| $5.26 | $6.65 | $8.90 | +28% | Bullish | |
| $5.67 | $7.26 | $9.90 | +40% | Bullish | |
| $5.46 | $7.07 | $9.79 | +36% | Bullish | |
| $6.08 | $7.97 | $11.19 | +54% | Bullish | |
| $7.28 | $9.65 | $13.73 | +86% | Bullish | |
| $7.59 | $10.16 | $14.64 | +96% | Bullish | |
| $7.86 | $10.62 | $15.47 | +105% | Bullish | |
| $10.60 | $14.94 | $22.82 | +188% | Bullish | |
| $16.54 | $25.02 | $40.98 | +382% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $5.16 | $5.19 | $6.12 | +0.00% |
| September 2026 | $4.53 | $5.31 | $6.36 | +2.23% |
| October 2026 | $4.65 | $5.48 | $6.62 | +3.22% |
| November 2026 | $4.60 | $5.44 | $6.62 | -0.59% |
| December 2026 | $4.58 | $5.44 | $6.65 | -0.08% |
Click any year to see its month-by-month ULBI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ULBI is projected to trade between $5.16 and $6.65, averaging $5.19 — a potential gain of 0% from today's $5.19. A consolidation phase looks the most probable path here.
Ultralife Corporation's 2027 outlook centres on $6.34, within a $5.19 to $8.08 range. That is up +22% on the projected 2026 average. That marks a +22% change versus current levels. Momentum favours further upside here.
By 2028, ULBI could reach as high as $8.36, with a base case around $6.38 and support toward $5.13 — roughly +23% from $5.19. Buyers look set to stay in control over this stretch.
Expect ULBI to range from $5.26 to $8.90 through 2029. The $6.65 average target implies a +28% move from current prices. That is up +4% on the projected 2028 average. Momentum favours further upside here.
The ULBI price prediction for 2030 points to an average of $7.26 (low $5.67, high $9.90) — a potential gain of +40% on today's $5.19. Buyers look set to stay in control over this stretch.
In 2031, ULBI is projected to trade between $5.46 and $9.79, averaging $7.07 — a potential gain of +36% from today's $5.19. That is -3% versus the projected 2030 average. Momentum favours further upside here.
Ultralife Corporation's 2032 outlook centres on $7.97, within a $6.08 to $11.19 range. That is up +13% on the projected 2031 average. That marks a +54% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, ULBI could reach as high as $13.73, with a base case around $9.65 and support toward $7.28 — roughly +86% from $5.19. Momentum favours further upside here.
Expect ULBI to range from $7.59 to $14.64 through 2034. The $10.16 average target implies a +96% move from current prices. That is up +5% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The ULBI price prediction for 2035 points to an average of $10.62 (low $7.86, high $15.47) — a potential gain of +105% on today's $5.19. Momentum favours further upside here.
In 2040, ULBI is projected to trade between $10.60 and $22.82, averaging $14.94 — a potential gain of +188% from today's $5.19. That is up +41% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Ultralife Corporation's 2050 outlook centres on $25.02, within a $16.54 to $40.98 range. That is up +67% on the projected 2040 average. That marks a +382% change versus current levels. Momentum favours further upside here.
Investing $1,000 in ULBI today (≈ 192.678227 ULBI) could be worth
$4,821.56
+$3,821.56 (+382%) by 2050 · US Dollar
Based on the average projected ULBI price of $25.02 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ULBIwould be worth at today's price.
$1,000 invested in ULBI on Jul 31, 2025 (≈ 125.470518 ULBI) would be worth
$651.19
-$348.81 (-34.9%) today · 0.65× · US Dollar
Based on a ULBI entry price of $7.97 vs. today's $5.19.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.3 | $979.25 | -2.1% |
| 1 month ago | $6.26 | $829.07 | -17.1% |
| 3 months ago | $6.86 | $756.56 | -24.3% |
| 6 months ago | $6.49 | $799.69 | -20.0% |
| 1 year ago | $7.97 | $651.19 | -34.9% |
| All time (5.0y) ago | $8.38 | $619.33 | -38.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ULBI forecast.
Our base-case forecast reaches $10.00 around 2034.
Implied market cap at $10.00: $166.57M
Year-by-year forecast highlights a gradual strengthening in the share price, starting with 2026 where the min is $5.25, avg $5.27, max $6.92, with ROI 0 and sentiment Neutral. From 2027 onward, the outlook becomes bullish, with 2027 avg $6.52 and ROI 23.6, 2028 avg $6.60 and ROI 25.2, and 2029 avg $7.05 and ROI 33.8. The 2030 forecast shows avg $7.72 and ROI 46.6, followed by continued gains through 2035 (avg $11.77, ROI 123.3).
By 2032 the avg is $8.83 (ROI 67.6) and 2033 avg $10.70 (ROI 103) with a max of $15.66, continuing to 2034 avg $11.04 (ROI 109.4) and 2035 avg $11.77 (ROI 123.3).
The longer-horizon forecast reaches $16.86 average by 2040 (ROI 219.9) and $28.99 average by 2050 (ROI 450.1), with corresponding max prices of $26.69 and $49.59 respectively. Sentiment is bullish across the latter years, reflecting higher expected prices and ROIs, though these are estimates and not guarantees. Investors should consider the inherent uncertainty and the possibility that actual results may differ from forecasts.
Tap a question to reveal the answer.
The forecast indicates an avg price of $7.72 in 2030 with a ROI of 46.6. The min is $5.93 and the max is $10.78, with bullish sentiment.
Forecasts show a neutral outlook in 2026 and bullish sentiment from 2027 onward, with rising averages and ROIs—2030 avg $7.72 (ROI 46.6), 2040 avg $16.86 (ROI 219.9), and 2050 avg $28.99 (ROI 450.1). These are estimates, not guarantees.
Yes, the forecast indicates a max in 2033 of $15.66, with earlier years showing smaller max values (e.g., 2032 max $12.75) and later years showing higher potential (2040 max $26.69; 2050 max $49.59).
In 2026, the min is $5.25, avg $5.27, max $6.92, with ROI 0 and sentiment Neutral.
The 2050 forecast shows avg $28.99, min $18.24, max $49.59, ROI 450.1, with bullish sentiment.
Ultralife Corporation Community Discussion
0Share your Ultralife Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.